Sign in
4/A

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-004070

Options or other derivatives

  • COO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LEE WILLIS C COO 2023-01-12 Grant or award · Options +500,000 $4.50 $2,250,000 500,000 D
Loading xslF345X03/doc4a.xml…